{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:43:45Z","timestamp":1793227425059,"version":"4.5.0"},"reference-count":272,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["FORT23\/00013"],"award-info":[{"award-number":["FORT23\/00013"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PT23\/00137"],"award-info":[{"award-number":["PT23\/00137"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI24\/01205"],"award-info":[{"award-number":["PI24\/01205"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI21\/01248"],"award-info":[{"award-number":["PI21\/01248"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon Europe","doi-asserted-by":"publisher","award":["101095679"],"award-info":[{"award-number":["101095679"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002418","name":"Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences and Peking Union Medical College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002418","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007761","name":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004433","name":"Chinese Pharmaceutical Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004433","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015755","name":"Biomedical Research Network Center of Hepatic and Digestive Diseases","doi-asserted-by":"publisher","award":["CECO-EHD002"],"award-info":[{"award-number":["CECO-EHD002"]}],"id":[{"id":"10.13039\/501100015755","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PI21\/01248"],"award-info":[{"award-number":["PI21\/01248"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PI24\/01205"],"award-info":[{"award-number":["PI24\/01205"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PT23\/00137"],"award-info":[{"award-number":["PT23\/00137"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["FORT23\/00013"],"award-info":[{"award-number":["FORT23\/00013"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009473","name":"University of Malaga","doi-asserted-by":"publisher","award":["PPRO-CTS1032-G-2023"],"award-info":[{"award-number":["PPRO-CTS1032-G-2023"]}],"id":[{"id":"10.13039\/100009473","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009473","name":"University of Malaga","doi-asserted-by":"publisher","award":["PPRO-CTS649-G-2023"],"award-info":[{"award-number":["PPRO-CTS649-G-2023"]}],"id":[{"id":"10.13039\/100009473","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["FPU22\/03868"],"award-info":[{"award-number":["FPU22\/03868"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["101095679"],"award-info":[{"award-number":["101095679"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["HORIZON-HLTH-2022-STAYHLTH-02"],"award-info":[{"award-number":["HORIZON-HLTH-2022-STAYHLTH-02"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PID2022-140169OB-C21\/MCIN\/AEI\/10.13039\/501100011033\/FEDER"],"award-info":[{"award-number":["PID2022-140169OB-C21\/MCIN\/AEI\/10.13039\/501100011033\/FEDER"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023731","name":"Regional Government of Andalusia Ministry of Health and Consumer Affairs","doi-asserted-by":"publisher","award":["RHJ-0052-2024"],"award-info":[{"award-number":["RHJ-0052-2024"]}],"id":[{"id":"10.13039\/501100023731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.apsb.2026.03.030","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:22:14Z","timestamp":1774311734000},"page":"3603-3631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Systematic review on genetic polymorphisms associated with idiosyncratic drug-induced liver injury (iDILI): iDILInet as an interactive visualization tool"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8295-6708","authenticated-orcid":false,"given":"Gonzalo","family":"Matilla-Cabello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0906-0740","authenticated-orcid":false,"given":"\u00c1ngela","family":"Remesal-Doblado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0635-9495","authenticated-orcid":false,"given":"Muazzez","family":"Celebi-Cinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2706-5202","authenticated-orcid":false,"given":"Ana","family":"Bodoque-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3692-347X","authenticated-orcid":false,"given":"Fatma Betul","family":"Metin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4976-5029","authenticated-orcid":false,"given":"Aida","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moiz","family":"Aftab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5152-2753","authenticated-orcid":false,"given":"Romina","family":"De los Santos-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3421-1792","authenticated-orcid":false,"given":"Antonio","family":"Segovia-Zafra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismael","family":"\u00c1lvarez-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal J.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulcin","family":"Cakan-Akdogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9586-4896","authenticated-orcid":false,"given":"M. Isabel","family":"Lucena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6223-5329","authenticated-orcid":false,"given":"Ozlen","family":"Konu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4728-201X","authenticated-orcid":false,"given":"Marina","family":"Villanueva-Paz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2026.03.030_bib1","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1136\/gutjnl-2016-313369","article-title":"Drug-induced liver injury: recent advances in diagnosis and risk assessment","volume":"66","author":"Kullak-Ublick","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.apsb.2026.03.030_bib2","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","article-title":"EASL clinical practice guidelines: dug-induced liver injury","volume":"70","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2026.03.030_bib3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-019-0105-0","article-title":"Drug-induced liver injury","volume":"5","author":"Andrade","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.apsb.2026.03.030_bib4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jhep.2015.04.016","article-title":"Drug-induced liver injury: interactions between drug properties and host factors","volume":"63","author":"Chen","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2026.03.030_bib5","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1053\/j.gastro.2016.12.016","article-title":"Association of liver injury from specific drugs, or groups of dugs, with polymorphisms in HLA and other genes in a enome-wide association study","volume":"152","author":"Nicoletti","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2026.03.030_bib6","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/hep.32689","article-title":"AASLD practice guidance on drug, herbal, and dietary supplement\u2013induced liver injury","volume":"77","author":"Fontana","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2026.03.030_bib7","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1007\/s11033-012-2433-y","article-title":"Slow N-acetyltransferase 2 genotype contributes to anti-tuberculosis drug-induced hepatotoxicity: a meta-analysis","volume":"40","author":"Du","year":"2013","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.apsb.2026.03.030_bib8","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1111\/bcp.13722","article-title":"The association between the NAT2 genetic polymorphisms and risk of DILI during anti-TB treatment: a systematic review and meta-analysis","volume":"84","author":"Zhang","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.apsb.2026.03.030_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047769","article-title":"Pharmacogenetic study of drug-metabolising enzyme polymorphisms on the risk of anti-tuberculosis drug-induced liver injury: a meta-analysis","volume":"7","author":"Cai","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2026.03.030_bib10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/FPC.0000000000000339","article-title":"NAT2 ultra-slow acetylator and risk of anti-tuberculosis drug-induced liver injury: a genotype-based meta-analysis","volume":"28","author":"Suvichapanich","year":"2018","journal-title":"Pharmacogenet Genom"},{"key":"10.1016\/j.apsb.2026.03.030_bib11","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1111\/liv.12836","article-title":"Pharmacogenetic testing in idiosyncratic drug-induced liver injury: current role in clinical practice","volume":"35","author":"Aithal","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.apsb.2026.03.030_bib12","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jhep.2018.05.013","article-title":"Pharmacogenomics of drug-induced liver injury (DILI): mlecular biology to clinical applications","volume":"69","author":"Kaliyaperumal","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2026.03.030_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/cts.13424","article-title":"Genetics of drug-induced liver injury: current knowledge and future prospects","volume":"16","author":"Daly","year":"2023","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.apsb.2026.03.030_bib14","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbae014","article-title":"Network propagation for GWAS analysis: a practical guide to leveraging molecular networks for disease gene discovery","volume":"25","author":"Visona","year":"2024","journal-title":"Briefings Bioinf"},{"key":"10.1016\/j.apsb.2026.03.030_bib15","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.gde.2013.09.003","article-title":"Network analysis of GWAS data","volume":"23","author":"Leiserson","year":"2013","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.apsb.2026.03.030_bib16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12920-022-01314-9","article-title":"PO2RDF: representation of real-world data for precision oncology using resource description framework","volume":"15","author":"Zhao","year":"2022","journal-title":"BMC Med Genom"},{"key":"10.1016\/j.apsb.2026.03.030_bib17","doi-asserted-by":"crossref","first-page":"e009378","DOI":"10.1136\/bmjgh-2022-009378","article-title":"Past, present and future of living systematic review: a bibliometrics analysis","volume":"7","author":"Zheng","year":"2022","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.apsb.2026.03.030_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.731933","article-title":"A bibliometric analysis of pyroptosis from 2001 to 2021","volume":"12","author":"Ma","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.03.030_bib19","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1089\/neu.2017.5583","article-title":"Genetic influences on patient-oriented outcomes in traumatic brain injury: a living systematic review of non-apolipoprotein E single-nucleotide polymorphisms","volume":"38","author":"Zeiler","year":"2021","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.apsb.2026.03.030_bib20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/zeb.2020.1869","article-title":"ZenoFishDb v1.1: a database for xenotransplantation studies in zebrafish","volume":"17","author":"Targen","year":"2020","journal-title":"Zebrafish"},{"key":"10.1016\/j.apsb.2026.03.030_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jclinepi.2023.02.005","article-title":"The life and death of living systematic reviews: a methodological survey","volume":"156","author":"Akl","year":"2023","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.apsb.2026.03.030_bib22","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.apsb.2026.03.030_bib23","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014A web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"10.1016\/j.apsb.2026.03.030_bib24","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/clpt.2011.58","article-title":"Case definition and phenotype standardization in drug-induced liver injury","volume":"89","author":"Aithal","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.apsb.2026.03.030_bib25","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0168-8278(90)90124-A","article-title":"Criteria of drug-induced liver disorders. Report of an international consensus meeting","volume":"11","author":"B\u00e9nichou","year":"1990","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2026.03.030_bib26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2165\/00002018-200932010-00005","article-title":"Drug-induced liver injury network (DILIN) prospective study: rationale, design and conduct","volume":"32","author":"Fontana","year":"2009","journal-title":"Drug Saf"},{"key":"10.1016\/j.apsb.2026.03.030_bib27","unstructured":"SERVICES USDOHAH. Common terminology criteria for adverse events (CTCAE). Available from:: https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm#ctc_50."},{"key":"10.1016\/j.apsb.2026.03.030_bib28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12863-015-0211-2","article-title":"Assessing the quality of published genetic association studies in meta-analyses: the quality of genetic studies (Q-Genie) tool","volume":"16","author":"Sohani","year":"2015","journal-title":"BMC Genet"},{"key":"10.1016\/j.apsb.2026.03.030_bib29","unstructured":"Laboratories K. KEGG: kyoto encyclopedia of genes and genomes. Available from:: https:\/\/www.genome.jp\/kegg\/."},{"key":"10.1016\/j.apsb.2026.03.030_bib30","unstructured":"Consortium GO. Gene ontology resource. Available from: https:\/\/geneontology.org."},{"key":"10.1016\/j.apsb.2026.03.030_bib31","unstructured":"Winston Chang JC, Jj Allaire, Carson Sievert, Barret Schloerke, Yihui Xie, Jeff Allen, et al. Shiny: web application framework for R. Available from: https:\/\/CRAN.R-project.org\/package=shiny."},{"key":"10.1016\/j.apsb.2026.03.030_bib32","series-title":"visNetwork: Network visualization using 'vis.js' Library","author":"Almende","year":"2025"},{"key":"10.1016\/j.apsb.2026.03.030_bib33","series-title":"A wrapper of the JavaScript Library 'DataTables'","author":"Yihui Xie","year":"2025"},{"key":"10.1016\/j.apsb.2026.03.030_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.apsb.2026.03.030_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abh2169","article-title":"A single-cell type transcriptomics map of human tissues","volume":"7","author":"Karlsson","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.apsb.2026.03.030_bib36","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2478\/raon-2013-0086","article-title":"Polymorphisms in folate pathway and pemetrexed treatment outcome in patients with malignant pleural mesothelioma","volume":"48","author":"Goricar","year":"2014","journal-title":"Radiol Oncol"},{"key":"10.1016\/j.apsb.2026.03.030_bib37","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2217\/epi-2017-0138","article-title":"Pharmacoepigenetics in childhood acute lymphoblastic leukemia: involvement of miRNA polymorphisms in hepatotoxicity","volume":"10","author":"Gutierrez-Camino","year":"2018","journal-title":"Epigenomics"},{"key":"10.1016\/j.apsb.2026.03.030_bib38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/08880018.2013.870625","article-title":"Association of \u201324CT, 1249GA, and 3972CT ABCC2 gene polymorphisms with methotrexate serum levels and toxic side effects in children with acute lymphoblastic leukemia","volume":"31","author":"Sharifi","year":"2014","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.apsb.2026.03.030_bib39","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.meegid.2017.04.001","article-title":"Association of CYP2B6 gene polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a Chinese population","volume":"51","author":"Wang","year":"2017","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.apsb.2026.03.030_bib40","article-title":"Association between genetic polymorphisms of NRF2, KEAP1, MAFF, MAFK and anti-tuberculosis drug-induced liver injury: a nested case-control study","volume":"9","author":"Chen","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2026.03.030_bib41","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1182\/blood-2006-05-022111","article-title":"Polymorphisms in DNA repair genes and therapeutic outcomes of AML patients from SWOG clinical trials","volume":"109","author":"Kuptsova","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.apsb.2026.03.030_bib42","doi-asserted-by":"crossref","first-page":"380","DOI":"10.4103\/ijmy.ijmy_143_18","article-title":"Polymorphisms of NAT2, CYP2E1, GST, and HLA related to drug-induced liver injury in Indonesian tuberculosis patients","volume":"7","author":"Perwitasari","year":"2018","journal-title":"Int J Mycobacteriol"},{"key":"10.1016\/j.apsb.2026.03.030_bib43","doi-asserted-by":"crossref","first-page":"9388","DOI":"10.18632\/oncotarget.11543","article-title":"Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma","volume":"8","author":"Hegyi","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.apsb.2026.03.030_bib44","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/bcpt.13284","article-title":"Association between genetic polymorphisms of SLCO1B1 and susceptibility to methimazole-induced liver injury","volume":"125","author":"Jin","year":"2019","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.apsb.2026.03.030_bib45","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/BS9.0000000000000142","article-title":"Effects of genetic polymorphisms on methotrexate levels and toxicity in Chinese patients with acute lymphoblastic leukemia","volume":"5","author":"Hao","year":"2023","journal-title":"Blood Sci"},{"key":"10.1016\/j.apsb.2026.03.030_bib46","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S1665-2681(19)31302-X","article-title":"Association of GST null genotypes with anti-tuberculosis drug induced hepatotoxicity in Western Indian population","volume":"12","author":"Gupta","year":"2013","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.apsb.2026.03.030_bib47","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1086\/507097","article-title":"Pharmacogenetics of nevirapine-associated hepatotoxicity: an adult AIDS clinical trials group collaboration","volume":"43","author":"Haas","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.apsb.2026.03.030_bib48","first-page":"1113","article-title":"Folate cycle gene variants and chemotherapy toxicity in pediatric patients with acute lymphoblastic leukemia","volume":"91","author":"Costea","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.apsb.2026.03.030_bib49","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1097\/QAI.0b013e31827ca50f","article-title":"Associations between HLA-DRB1\u22170102, HLA-B\u22175801, and hepatotoxicity during initiation of nevirapine-containing regimens in South Africa","volume":"62","author":"Phillips","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.apsb.2026.03.030_bib50","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1038\/s41598-018-38452-z","article-title":"Association of PXR and CAR polymorphisms and antituberculosis drug-induced hepatotoxicity","volume":"9","author":"Wang","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2026.03.030_bib51","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/cpt.2100","article-title":"Genetic risk factors in drug-induced liver injury due to isoniazid-containing antituberculosis drug regimens","volume":"109","author":"Nicoletti","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.apsb.2026.03.030_bib52","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s40261-017-0572-6","article-title":"Genetic polymorphisms of SLCO1B1, CYP2E1 and UGT1A1 and susceptibility to anti-tuberculosis drug-induced hepatotoxicity: a Chinese population-based prospective case\u2013control study","volume":"37","author":"Sun","year":"2017","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.apsb.2026.03.030_bib53","article-title":"Genetic polymorphisms in PXR and NF-\u03baB1 influence susceptibility to anti-tuberculosis drug-induced liver injury","volume":"14","author":"Zhang","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2026.03.030_bib54","first-page":"800","article-title":"Polymorphisms within methotrexate pathway genes: relationship between plasma methotrexate levels, toxicity experienced and outcome in pediatric acute lymphoblastic leukemia","volume":"23","author":"Esmaili","year":"2020","journal-title":"Iran J Basic Med Sci"},{"key":"10.1016\/j.apsb.2026.03.030_bib55","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1093\/jpp\/rgab099","article-title":"Association between SNPs and hepatotoxicity in patients with primary central nervous system lymphoma on high-dose methotrexate therapy","volume":"73","author":"Zhao","year":"2021","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.apsb.2026.03.030_bib56","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1086\/507101","article-title":"Drug transporter and metabolizing enzyme gene variants and nonnucleoside reverse-transcriptase inhibitor hepatotoxicity","volume":"43","author":"Ritchie","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.apsb.2026.03.030_bib57","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/phar.2349","article-title":"Genetic polymorphisms in antioxidant enzymes modulate the susceptibility of idiosyncratic antituberculous drug-induced liver injury and treatment outcomes in patients with tuberculosis","volume":"40","author":"Sun","year":"2020","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.apsb.2026.03.030_bib58","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/MPG.0000000000001502","article-title":"Analysis of immunogenetic factors in idiosyncratic drug-induced liver injury in the pediatric population","volume":"64","author":"Ocete-Hita","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.apsb.2026.03.030_bib59","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/jcpt.13452","article-title":"A validation study of the UGT1A4 rs2011404 variant and the risk of anti-tuberculosis drug-induced hepatotoxicity in an eastern Chinese Han population","volume":"46","author":"Zhu","year":"2021","journal-title":"J Clin Pharm Therapeut"},{"key":"10.1016\/j.apsb.2026.03.030_bib60","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2217\/pgs.09.142","article-title":"Nevirapine-induced hepatotoxicity and pharmacogenetics: a retrospective study in a population from Mozambique","volume":"11","author":"Ciccacci","year":"2010","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.apsb.2026.03.030_bib61","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.jhep.2010.05.033","article-title":"Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury","volume":"53","author":"Donaldson","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2026.03.030_bib62","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017821","article-title":"The genetic variants in calcium signaling related genes influence anti-tuberculosis drug induced liver injury: a prospective study","volume":"98","author":"Lyu","year":"2019","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.apsb.2026.03.030_bib63","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.5588\/ijtld.15.0310","article-title":"NAT2 slow acetylator associated with anti-tuberculosis drug-induced liver injury in Thai patients","volume":"20","author":"Wattanapokayakit","year":"2016","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.apsb.2026.03.030_bib64","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/MBC.0b013e32835b249d","article-title":"C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: effect on methotrexate-related toxicity in adult acute lymphoblastic leukaemia","volume":"24","author":"Eissa","year":"2013","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.apsb.2026.03.030_bib65","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jhep.2022.09.010","article-title":"Clinical features, outcomes, and HLA risk factors associated with nitrofurantoin-induced liver injury","volume":"78","author":"Chalasani","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2026.03.030_bib66","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1440-1746.2010.06355.x","article-title":"Role of polymorphic N-acetyl transferase2 and cytochrome P4502E1 gene in antituberculosis treatment-induced hepatitis","volume":"26","author":"Bose","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2026.03.030_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027810","article-title":"Pharmacogenetic & pharmacokinetic biomarker for efavirenz based arv and rifampicin based anti-tb drug induced liver injury in TB-HIV infected patients","volume":"6","author":"Yimer","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2026.03.030_bib68","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s40880-016-0145-8","volume":"35","author":"Qian","year":"2016","journal-title":"Chin J Cancer"},{"key":"10.1016\/j.apsb.2026.03.030_bib69","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijid.2014.04.011","article-title":"Association of the CYP2B6 gene with anti-tuberculosis drug-induced hepatotoxicity in a Brazilian Amazon population","volume":"33","author":"Fernandes","year":"2015","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.apsb.2026.03.030_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186200","article-title":"Association and clinical utility of NAT2 in the prediction of isoniazid-induced liver injury in Singaporean patients","volume":"12","author":"Chan","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2026.03.030_bib71","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02692-18","article-title":"Genomewide association study confirming the association of NAT2 with susceptibility to antituberculosis drug-induced liver injury in Thai patients","volume":"63","author":"Suvichapanich","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2026.03.030_bib72","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/tpj.2016.7","article-title":"Expression and polymorphism (rs4880) of mitochondrial superoxide dismutase (SOD2) and asparaginase induced hepatotoxicity in adult patients with acute lymphoblastic leukemia","volume":"17","author":"Alachkar","year":"2017","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.apsb.2026.03.030_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2019.104147","article-title":"Association of POR and PPARalpha polymorphisms with risk of anti-tuberculosis drug-induced liver injury in Western Chinese Han population","volume":"79","author":"Zhang","year":"2020","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.apsb.2026.03.030_bib74","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1053\/j.gastro.2006.11.023","article-title":"Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes","volume":"132","author":"Daly","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2026.03.030_bib75","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/hep.22370","article-title":"Glutathione S-transferase M1 and T1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury","volume":"48","author":"Lucena","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2026.03.030_bib76","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jhep.2007.02.009","article-title":"Genetic polymorphisms of manganese superoxide dismutase, NAD(P)H:quinone oxidoreductase, glutathione S-transferase M1 and T1, and the susceptibility to drug-induced liver injury","volume":"47","author":"Huang","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2026.03.030_bib77","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.tube.2007.05.012","article-title":"Genetic polymorphisms of NAT2 and CYP2E1 associated with antituberculosis drug-induced hepatotoxicity in Korean patients with pulmonary tuberculosis","volume":"87","author":"Cho","year":"2007","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.apsb.2026.03.030_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph182010603","article-title":"Machine learning to identify interaction of single-nucleotide polymorphisms as a risk factor for chronic drug-induced liver injury","volume":"18","author":"Moore","year":"2021","journal-title":"Int J Environ Res Publ Health"},{"key":"10.1016\/j.apsb.2026.03.030_bib79","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/hep.20205","article-title":"Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity","volume":"39","author":"Aithal","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2026.03.030_bib80","first-page":"11594","article-title":"CCND1 G870A polymorphism is associated with toxicity of methotrexate in childhood acute lymphoblastic leukemia","volume":"8","author":"Xue","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.apsb.2026.03.030_bib81","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/jhg.2016.10","article-title":"NAT2 variants are associated with drug-induced liver injury caused by anti-tuberculosis drugs in Indonesian patients with tuberculosis","volume":"61","author":"Yuliwulandari","year":"2016","journal-title":"J Hum Genet"},{"key":"10.1016\/j.apsb.2026.03.030_bib82","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jhep.2017.03.010","article-title":"Minocycline hepatotoxicity: clinical characterization and identification of HLA-B\u221735:02 as a risk factor","volume":"67","author":"Urban","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2026.03.030_bib83","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.tube.2014.11.004","article-title":"Association of polymorphisms in drug transporter genes (SLCO1B1 and SLC10A1) and anti-tuberculosis drug-induced hepatotoxicity in a Chinese cohort","volume":"95","author":"Chen","year":"2015","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.apsb.2026.03.030_bib84","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/MPH.0000000000000535","article-title":"Some GCR polymorphisms (N363S, ER22\/23EK, and Bcl-1) may influence steroid-induced toxicities and survival rates in children with ALL","volume":"38","author":"Eipel","year":"2016","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.apsb.2026.03.030_bib85","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3390\/genes11040468","article-title":"Pharmacogenomic markers of methotrexate response in the consolidation phase of pediatric acute lymphoblastic leukemia treatment","volume":"11","author":"Kotur","year":"2020","journal-title":"Genes"},{"key":"10.1016\/j.apsb.2026.03.030_bib86","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1177\/1078155218818244","article-title":"Comprehensive analysis of Methylenetetrahydrofolate reductase C677T in younger acute lymphoblastic leukemia patients: a single-center experience","volume":"25","author":"Frikha","year":"2019","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.apsb.2026.03.030_bib87","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1053\/j.gastro.2011.04.001","article-title":"Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles","volume":"141","author":"Lucena","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2026.03.030_bib88","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.2217\/pgs-2017-0110","article-title":"SLCO1B1 rs4149056 genetic polymorphism predicting methotrexate toxicity in Chinese patients with Non-Hodgkin lymphoma","volume":"18","author":"Yang","year":"2017","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.apsb.2026.03.030_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2019.103970","article-title":"Association of LEPR polymorphisms with predisposition and inflammatory response in anti-tuberculosis drug-induced liver injury: a pilot prospective investigation in Western Chinese Han population","volume":"75","author":"Zhao","year":"2019","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.apsb.2026.03.030_bib90","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1590\/0001-3765201420130350","article-title":"Polymorphisms in CYP2E1, GSTM1 and GSTT1 and anti-tuberculosis drug-induced hepatotoxicity","volume":"86","author":"Brito","year":"2014","journal-title":"An Acad Bras Ci\u00eancias"},{"key":"10.1016\/j.apsb.2026.03.030_bib91","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.3748\/wjg.v26.i12.1329","article-title":"Single-nucleotide polymorphisms of HLA and Polygonum multiflorum-induced liver injury in the Han Chinese population","volume":"26","author":"Yang","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.apsb.2026.03.030_bib92","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/jcpt.13672","article-title":"The role of the genetic variant FECH rs11660001 in the occurrence of anti-tuberculosis drug-induced liver injury","volume":"47","author":"Zhang","year":"2022","journal-title":"J Clin Pharm Therapeut"},{"key":"10.1016\/j.apsb.2026.03.030_bib93","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1200\/JCO.2010.31.3197","article-title":"HLA-DQA1\u221702:01 is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer","volume":"29","author":"Spraggs","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.apsb.2026.03.030_bib94","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2217\/pgs-2022-0022","article-title":"NAT2 polymorphism and clinical factors that increase antituberculosis drug-induced hepatotoxicity","volume":"23","author":"Mohamed Noor","year":"2022","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.apsb.2026.03.030_bib95","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1089\/jayao.2019.0180","article-title":"CYP genotypes are associated with toxicity and survival in osteosarcoma patients","volume":"9","author":"Trujillo-Paolillo","year":"2020","journal-title":"J Adolesc Young Adult Oncol"},{"key":"10.1016\/j.apsb.2026.03.030_bib96","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ng.379","article-title":"HLA-B\u22175701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin","volume":"41","author":"Daly","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.apsb.2026.03.030_bib97","first-page":"81","article-title":"Determining the relation between N-acetyltransferase-2 acetylator phenotype and antituberculosis drug induced hepatitis by molecular biologic tests","volume":"56","author":"Bozok Cetinta\u015f","year":"2008","journal-title":"Tuberk Toraks"},{"key":"10.1016\/j.apsb.2026.03.030_bib98","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1111\/jgh.12194","article-title":"Association of N-acetyltransferase 2 and cytochrome P450 2E1 gene polymorphisms with antituberculosis drug-induced hepatotoxicity in Western India","volume":"28","author":"Gupta","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2026.03.030_bib99","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/tpj.2014.75","article-title":"Association study of UGT1A9 promoter polymorphisms with DILI based on systematically regional variation screen in Chinese population","volume":"15","author":"Jiang","year":"2015","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.apsb.2026.03.030_bib100","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1007\/s00535-017-1405-3","article-title":"Association between alanine aminotransferase elevation and UGT1A1\u22176 polymorphisms in daclatasvir and asunaprevir combination therapy for chronic hepatitis C","volume":"53","author":"Maekawa","year":"2018","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.apsb.2026.03.030_bib101","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3109\/08880011003739422","article-title":"Association of genetic polymorphisms with hepatotoxicity in patients with childhood acute lymphoblastic leukemia or lymphoma","volume":"27","author":"Horinouchi","year":"2010","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.apsb.2026.03.030_bib102","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.tube.2014.02.003","article-title":"Association of NAT2, GST and CYP2E1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity","volume":"94","author":"Singla","year":"2014","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.apsb.2026.03.030_bib103","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/FPC.0000000000000370","article-title":"Association of FAM65B, AGBL4, and CUX2 genetic polymorphisms with susceptibility to antituberculosis drug-induced hepatotoxicity: validation study in a Chinese Han population","volume":"29","author":"Pan","year":"2019","journal-title":"Pharmacogenet Genom"},{"key":"10.1016\/j.apsb.2026.03.030_bib104","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/tpj.2011.34","article-title":"High plasma efavirenz level and CYP2B6\u22176 are associated with efavirenz-based HAART-induced liver injury in the treatment of na\u00efve HIV patients from Ethiopia: a prospective cohort study","volume":"12","author":"Yimer","year":"2012","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.apsb.2026.03.030_bib105","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/jcpt.12818","article-title":"Possible association of HMOX1 and NQO1 polymorphisms with anti-tuberculosis drug-induced liver injury: a matched case-control study","volume":"44","author":"Yang","year":"2019","journal-title":"J Clin Pharm Therapeut"},{"key":"10.1016\/j.apsb.2026.03.030_bib106","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/hep.23668","article-title":"Mitochondrial superoxide dismutase and glutathione peroxidase in idiosyncratic drug-induced liver injury","volume":"52","author":"Lucena","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2026.03.030_bib107","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/FPC.0000000000000224","article-title":"tagSNP rs1495741 as a useful molecular marker to predict antituberculosis drug-induced hepatotoxicity","volume":"26","author":"Chamorro","year":"2016","journal-title":"Pharmacogenet Genom"},{"key":"10.1016\/j.apsb.2026.03.030_bib108","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/hep.23549","article-title":"A role for the pregnane X receptor in flucloxacillin-induced liver injury","volume":"51","author":"Andrews","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2026.03.030_bib109","doi-asserted-by":"crossref","DOI":"10.4238\/gmr.15038296","article-title":"Association between TXNRD1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a prospective study","volume":"15","author":"Ji","year":"2016","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.apsb.2026.03.030_bib110","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1478-3231.2011.02697.x","article-title":"TNF-\u03b1 genetic polymorphism-308G\/A and antituberculosis drug-induced hepatitis","volume":"32","author":"Kim","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.apsb.2026.03.030_bib111","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/jcpt.12105","article-title":"N-Acetyltransferase 2, cytochrome P4502E1 and glutathione S-transferase genotypes in antitubercular treatment-induced hepatotoxicity in North Indians","volume":"39","author":"Rana","year":"2014","journal-title":"J Clin Pharm Therapeut"},{"key":"10.1016\/j.apsb.2026.03.030_bib112","doi-asserted-by":"crossref","first-page":"115456","DOI":"10.18632\/oncotarget.23297","article-title":"Clinical relevance of LINC00152 and its variants in Western Chinese tuberculosis patients","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.apsb.2026.03.030_bib113","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00228-020-02934-9","article-title":"ABCB1 and ERCC1 gene polymorphisms are associated with nephro- and hepatotoxicity to carboplatin\/paclitaxel-based chemotherapy in patients with gynecologic cancers","volume":"76","author":"da Costa Junior","year":"2020","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.apsb.2026.03.030_bib114","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1053\/jhep.2003.50144","article-title":"Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis","volume":"37","author":"Huang","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2026.03.030_bib115","doi-asserted-by":"crossref","DOI":"10.1177\/1533033821995288","article-title":"Study on relationships of tumor status and gene polymorphism with blood concentration of MTX and toxicities in 63 pediatric mature B cell lymphoma in Chinese population","volume":"20","author":"Huang","year":"2021","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.apsb.2026.03.030_bib116","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/s41588-018-0168-y","article-title":"Common variation near IRF6 is associated with IFN-\u03b2-induced liver injury in multiple sclerosis","volume":"50","author":"Kowalec","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.apsb.2026.03.030_bib117","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040180","article-title":"Liver enzyme abnormalities and associated risk factors in HIV patients on efavirenz-based HAART with or without tuberculosis co-infection in Tanzania","volume":"7","author":"Mugusi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2026.03.030_bib118","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1016\/j.apsb.2022.02.006","article-title":"FOXO3 mutation predicting gefitinib-induced hepatotoxicity in NSCLC patients through regulation of autophagy","volume":"12","author":"Guan","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.03.030_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109095","article-title":"Association of HLA-C\u221703:02 with methimazole-induced liver injury in Graves' disease patients","volume":"117","author":"Li","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.apsb.2026.03.030_bib120","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/1348-0421.12877","article-title":"Prospective study of ALDH1A1 gene polymorphisms associated with antituberculosis drug-induced liver injury in Western Chinese Han population","volume":"65","author":"Peng","year":"2021","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.apsb.2026.03.030_bib121","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3390\/jpm12050790","article-title":"Clinical and genetic risk factors for drug-induced liver injury associated with anti-tuberculosis treatment-a study from patients of portuguese health centers","volume":"12","author":"Cavaco","year":"2022","journal-title":"J Personalized Med"},{"key":"10.1016\/j.apsb.2026.03.030_bib122","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijid.2019.12.004","article-title":"Do genetic polymorphisms of B-cell CLL\/lymphoma 2 confer susceptibility to anti-tuberculous therapy-associated drug-induced liver injury?.","volume":"91","author":"Lyu","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.apsb.2026.03.030_bib123","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.tube.2011.12.004","article-title":"Genetic variants in antioxidant pathway: risk factors for hepatotoxicity in tuberculosis patients","volume":"92","author":"Nanashima","year":"2012","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.apsb.2026.03.030_bib124","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/jcpt.13625","article-title":"Interaction between the HIF-1\u03b1 gene rs1957757 polymorphism and CpG island methylation in the promoter region is associated with the risk of anti-tuberculosis drug-induced liver injury in humans: a case-control study","volume":"47","author":"Chong","year":"2022","journal-title":"J Clin Pharm Therapeut"},{"key":"10.1016\/j.apsb.2026.03.030_bib125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068111","article-title":"HLA alleles influence the clinical signature of amoxicillin-clavulanate hepatotoxicity","volume":"8","author":"Stephens","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2026.03.030_bib126","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/hep.31258","article-title":"Human leukocyte antigen B\u221714:01 and B\u221735:01 are associated with trimethoprim-sulfamethoxazole induced liver injury","volume":"73","author":"Li","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2026.03.030_bib127","doi-asserted-by":"crossref","first-page":"200","DOI":"10.14309\/ajg.0000000000002454","article-title":"HLA-B\u221753:01 is a significant risk factor of liver injury due to phenytoin and other antiepileptic drugs in African Americans","volume":"119","author":"Nicoletti","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.apsb.2026.03.030_bib128","first-page":"75","article-title":"SLCO1B1 \u221715 haplotype is associated with rifampin-induced liver injury","volume":"6","author":"Li","year":"2012","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.apsb.2026.03.030_bib129","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1111\/liv.14903","article-title":"Allopurinol hepatotoxicity is associated with human leukocyte antigen Class I alleles","volume":"41","author":"Fontana","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.apsb.2026.03.030_bib130","first-page":"353","article-title":"Superoxide dismutase 2 Val16Ala polymorphism is associated with amiodarone-associated liver injury","volume":"23","author":"Radmanovic","year":"2022","journal-title":"Exp Appl Biomed Res"},{"key":"10.1016\/j.apsb.2026.03.030_bib131","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/ng.632","article-title":"A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury","volume":"42","author":"Singer","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.apsb.2026.03.030_bib132","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/sj.tpj.6500442","article-title":"Ticlopidine-induced hepatotoxicity is associated with specific human leukocyte antigen genomic subtypes in Japanese patients: a preliminary case-control study","volume":"8","author":"Hirata","year":"2008","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.apsb.2026.03.030_bib133","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1440-1681.2012.05713.x","article-title":"NAT2 and CYP2E1 polymorphisms associated with antituberculosis drug-induced hepatotoxicity in Chinese patients","volume":"39","author":"An","year":"2012","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.apsb.2026.03.030_bib134","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1124\/dmd.114.061325","article-title":"No contribution of the ABCB11 p.444A polymorphism in Japanese patients with drug-induced cholestasis","volume":"43","author":"Kagawa","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.apsb.2026.03.030_bib135","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.bjid.2019.09.003","article-title":"Relationship of anti-tuberculosis drug-induced liver injury and genetic polymorphisms in CYP2E1 and GST","volume":"23","author":"Santos","year":"2019","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.apsb.2026.03.030_bib136","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/hep.23891","article-title":"Polymerase \u03b3 gene POLG determines the risk of sodium valproate-induced liver toxicity","volume":"52","author":"Stewart","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2026.03.030_bib137","doi-asserted-by":"crossref","first-page":"e1416","DOI":"10.1016\/j.cgh.2021.08.015","article-title":"Garcinia cambogia, either alone or in combination with green tea, causes moderate to severe liver injury","volume":"20","author":"Vuppalanchi","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2026.03.030_bib138","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3096","article-title":"Relevance of NAT2 genotype to anti-tuberculosis drug-induced hepatotoxicity in a Chinese Han population","volume":"21","author":"Lu","year":"2019","journal-title":"J Gene Med"},{"key":"10.1016\/j.apsb.2026.03.030_bib139","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/cpt.924","article-title":"Antituberculosis drug-induced adverse events in the liver, kidneys, and blood: clinical profiles and pharmacogenetic predictors","volume":"104","author":"Hu","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.apsb.2026.03.030_bib140","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41397-019-0115-z","article-title":"Polymorphisms of NF-\u03baB pathway genes influence adverse drug reactions of gefitinib in NSCLC patients","volume":"20","author":"Xin","year":"2020","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.apsb.2026.03.030_bib141","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4168\/aair.2015.7.1.88","article-title":"Superoxide dismutase gene (SOD1, SOD2, and SOD3) polymorphisms and antituberculosis drug-induced hepatitis","volume":"7","author":"Kim","year":"2015","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.apsb.2026.03.030_bib142","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3389\/fped.2020.00307","article-title":"Polymorphisms of SLC19A1 80 G>A, MTHFR 677 C>T, and tandem TS repeats influence pharmacokinetics, acute liver toxicity, and vomiting in children with acute lymphoblastic leukemia treated with high doses of methotrexate","volume":"8","author":"Cwiklinska","year":"2020","journal-title":"Front Pediatr"},{"key":"10.1016\/j.apsb.2026.03.030_bib143","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1685128","article-title":"The variant at TGFBRAP1 but not TGFBR2 is associated with antituberculosis drug-induced liver injury","volume":"2019","author":"Zhang","year":"2019","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.apsb.2026.03.030_bib144","doi-asserted-by":"crossref","first-page":"376","DOI":"10.5588\/ijtld.11.0404","article-title":"UGT1A1 polymorphisms associated with risk of induced liver disorders by anti-tuberculosis medications","volume":"16","author":"Chang","year":"2012","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.apsb.2026.03.030_bib145","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/FPC.0000000000000300","article-title":"Effect of gene-gene and gene-environment interactions associated with antituberculosis drug-induced hepatotoxicity","volume":"27","author":"Chamorro","year":"2017","journal-title":"Pharmacogenet Genom"},{"key":"10.1016\/j.apsb.2026.03.030_bib146","doi-asserted-by":"crossref","first-page":"812","DOI":"10.5588\/ijtld.15.0450","article-title":"CYP7A1, BAAT and UGT1A1 polymorphisms and susceptibility to anti-tuberculosis drug-induced hepatotoxicity","volume":"20","author":"Chen","year":"2016","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.apsb.2026.03.030_bib147","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.tube.2018.05.011","article-title":"rs1800796 of the IL6 gene is associated with increased risk for anti-tuberculosis drug-induced hepatotoxicity in Chinese Han children","volume":"111","author":"Li","year":"2018","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.apsb.2026.03.030_bib148","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/jcph.1398","article-title":"The A\/A genotype of XPO1 rs4430924 is associated with higher risk of antituberculosis drug-induced hepatotoxicity in Chinese patients","volume":"59","author":"He","year":"2019","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.apsb.2026.03.030_bib149","doi-asserted-by":"crossref","first-page":"499","DOI":"10.5588\/ijtld.12.0645","article-title":"N-Acetyl transferase 2 and cytochrome P450 2E1 genes and isoniazid-induced hepatotoxicity in Brazilian patients","volume":"17","author":"Santos","year":"2013","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.apsb.2026.03.030_bib150","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1177\/147323001003800324","article-title":"Genetic polymorphisms of cytochrome P450 and glutathione S-transferase associated with antituberculosis drug-induced hepatotoxicity in Chinese tuberculosis patients","volume":"38","author":"Wang","year":"2010","journal-title":"J Int Med Res"},{"key":"10.1016\/j.apsb.2026.03.030_bib151","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1053\/j.gastro.2022.11.036","article-title":"Identification of reduced ERAP2 expression and a novel HLA allele as components of a risk score for susceptibility to liver injury due to amoxicillin-clavulanate","volume":"164","author":"Nicoletti","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2026.03.030_bib152","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2217\/pgs-2020-0080","article-title":"Clinical and genetic risk factors for the prediction of hepatotoxicity induced by a docetaxel, epirubicin and cyclophosphamide regimen in breast cancer patients","volume":"22","author":"Huang","year":"2021","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.apsb.2026.03.030_bib153","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219022","article-title":"Single nucleotide polymorphisms associated with elevated alanine aminotransferase in patients receiving asunaprevir plus daclatasvir combination therapy for chronic hepatitis C","volume":"14","author":"Kato","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2026.03.030_bib154","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cca.2021.04.017","article-title":"NAT2 polymorphisms associated with the development of hepatotoxicity after first-line tuberculosis treatment in Mexican patients: from genotype to molecular structure characterization","volume":"519","author":"Herrera-Rodulfo","year":"2021","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.apsb.2026.03.030_bib155","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41397-020-0159-0","article-title":"HLA associations with infliximab-induced liver injury","volume":"20","author":"Bruno","year":"2020","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.apsb.2026.03.030_bib156","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1097\/CAD.0000000000001360","article-title":"Association of genetic polymorphisms of CYP3A4 and CYP2D6 with gefitinib-induced toxicities","volume":"33","author":"Kwok","year":"2022","journal-title":"Anti Cancer Drugs"},{"key":"10.1016\/j.apsb.2026.03.030_bib157","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.3109\/10428194.2013.825902","article-title":"Methylenetetrahydrofolate reductase gene haplotypes affect toxicity during maintenance therapy for childhood acute lymphoblastic leukemia in Japanese patients","volume":"55","author":"Tanaka","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.apsb.2026.03.030_bib158","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1200\/JCO.2013.52.9867","article-title":"Prospective validation of HLA-DRB1\u221707:01 allele carriage as a predictive risk factor for lapatinib-induced liver injury","volume":"32","author":"Schaid","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.apsb.2026.03.030_bib159","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/FPC.0b013e32835e95e1","article-title":"The NAT2 tag SNP rs1495741 correlates with the susceptibility of antituberculosis drug-induced hepatotoxicity","volume":"23","author":"Ho","year":"2013","journal-title":"Pharmacogenet Genom"},{"key":"10.1016\/j.apsb.2026.03.030_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2020.106166","article-title":"The PNPLA3 rs738409 variant can increase the risk of liver toxicity in multiple sclerosis patients treated with beta-interferon","volume":"197","author":"Capone","year":"2020","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.apsb.2026.03.030_bib161","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cca.2012.10.030","article-title":"Relationship of NAT2, CYP2E1 and GSTM1\/GSTT1 polymorphisms with mild elevation of liver enzymes in Brazilian individuals under anti-tuberculosis drug therapy","volume":"415","author":"Forestiero","year":"2013","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.apsb.2026.03.030_bib162","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/QAD.0b013e32834779df","article-title":"Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent","volume":"25","author":"Yuan","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.apsb.2026.03.030_bib163","article-title":"Genetic polymorphisms of glutathione S-transferase P1 (GSTP1) and the incidence of anti-tuberculosis drug-induced hepatotoxicity","volume":"11","author":"Wu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2026.03.030_bib164","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.tube.2016.07.006","article-title":"Factors associated with anti-TB drug-induced hepatotoxicity and genetic polymorphisms in Indigenous and non-indigenous populations in Brazil","volume":"101","author":"Heinrich","year":"2016","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.apsb.2026.03.030_bib165","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1053\/jhep.2002.32102","article-title":"Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis","volume":"35","author":"Huang","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2026.03.030_bib166","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00432-020-03476-4","article-title":"Impact of STAT1 polymorphisms on crizotinib-induced hepatotoxicity in ALK-positive non-small cell lung cancer patients","volume":"147","author":"Xin","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.apsb.2026.03.030_bib167","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3389\/fphar.2020.00267","article-title":"Screening of novel pharmacogenetic candidates for mercaptopurine-induced toxicity in patients with acute lymphoblastic leukemia","volume":"11","author":"Cao","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2026.03.030_bib168","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2021.104991","article-title":"Relationship between xanthine oxidase gene polymorphisms and anti-tuberculosis drug-induced liver injury in a Chinese population","volume":"93","author":"Ai","year":"2021","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.apsb.2026.03.030_bib169","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s12094-012-0936-6","article-title":"Specific genetic polymorphisms of IL10-592 AA and IL10-819 TT genotypes lead to the key role for inducing docetaxel-induced liver injury in breast cancer patients","volume":"15","author":"Liang","year":"2013","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.apsb.2026.03.030_bib170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051723","article-title":"Polymorphisms in CTLA4 influence incidence of drug-induced liver injury after renal transplantation in Chinese recipients","volume":"7","author":"Guo","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2026.03.030_bib171","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.726229","article-title":"A risk scoring model for high-dose methotrexate-induced liver injury in children with acute lymphoblastic leukemia based on gene polymorphism study","volume":"12","author":"He","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2026.03.030_bib172","doi-asserted-by":"crossref","first-page":"924","DOI":"10.4103\/ijmr.IJMR_684_14","article-title":"Genetic polymorphisms of N-acetyltransferase 2 & susceptibility to antituberculosis drug-induced hepatotoxicity","volume":"144","author":"Sharma","year":"2016","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.apsb.2026.03.030_bib173","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2019.01.034","article-title":"A missense variant in PTPN22 is a risk factor for drug-induced liver injury","volume":"156","author":"Cirulli","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2026.03.030_bib175","series-title":"Autoimmunity. From bench to bedside","first-page":"169","article-title":"Major histocompatibility complex: antigen processing presentation. Chapter 10","author":"Anaya","year":"2013"},{"key":"10.1016\/j.apsb.2026.03.030_bib176","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3390\/antiox10030390","article-title":"Oxidative stress in drug-induced liver injury (DILI): from mechanisms to biomarkers for use in clinical practice","volume":"10","author":"Villanueva-Paz","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.apsb.2026.03.030_bib177","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/bs.apha.2019.01.006","article-title":"Cell death in drug-induced liver injury","volume":"85","author":"Iorga","year":"2019","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.apsb.2026.03.030_bib178","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.3390\/ijms18051018","article-title":"Drug-induced liver injury: cascade of events leading to cell death, apoptosis or necrosis","volume":"18","author":"Iorga","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.03.030_bib179","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1016\/j.apsb.2021.10.003","article-title":"Mechanisms of immune checkpoint inhibitor-mediated liver injury","volume":"11","author":"Shojaie","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.03.030_bib180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082562","article-title":"Polymorphic cytochrome P450 enzymes (CYPs) and their role in personalized therapy","volume":"8","author":"Preissner","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2026.03.030_bib181","doi-asserted-by":"crossref","first-page":"9006","DOI":"10.1021\/bi00425a019","article-title":"Human ethanol-inducible P450IIE1: complete gene sequence, promoter characterization, chromosome mapping, and cDNA-directed expression","volume":"27","author":"Umeno","year":"1988","journal-title":"Biochemistry"},{"key":"10.1016\/j.apsb.2026.03.030_bib182","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1111\/j.1530-0277.2006.00284.x","article-title":"Role of the genetic polymorphisms in the 5\u2032-flanking region for transcriptional regulation of the human CYP2E1 gene","volume":"31","author":"Uchimoto","year":"2007","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.apsb.2026.03.030_bib183","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/oxfordjournals.jbchem.a124526","article-title":"Different regulation and expression of the human CYP2E1 gene due to the RsaI polymorphism in the 5\u2032-flanking region","volume":"116","author":"Watanabe","year":"1994","journal-title":"J Biochem"},{"key":"10.1016\/j.apsb.2026.03.030_bib184","doi-asserted-by":"crossref","first-page":"42S","DOI":"10.1097\/01.ALC.0000078612.01626.96","article-title":"Transcriptional activity of the tandem repeat polymorphism in the 5\u2032-flanking region of the human CYP2E1 gene","volume":"27","author":"Nomura","year":"2003","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.apsb.2026.03.030_bib185","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1124\/dmd.111.042416","article-title":"Effects of the CYP2B6\u22176 allele on catalytic properties and inhibition of CYP2B6 in vitro: implication for the mechanism of reduced efavirenz metabolism and other CYP2B6 substrates in vivo","volume":"40","author":"Xu","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.apsb.2026.03.030_bib186","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1124\/jpet.107.133306","article-title":"Aberrant splicing caused by single nucleotide polymorphism c.516G>T [Q172H], a marker of CYP2B6\u22176, is responsible for decreased expression and activity of CYP2B6 in liver","volume":"325","author":"Hofmann","year":"2008","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.apsb.2026.03.030_bib187","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00228-022-03424-w","article-title":"Impacts of pregnane X receptor and cytochrome P450 oxidoreductase gene polymorphisms on trough concentrations of apixaban in patients with non-valvular atrial fibrillation","volume":"79","author":"Nakagawa","year":"2023","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.apsb.2026.03.030_bib188","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41397-018-0061-1","article-title":"Impact of single nucleotide polymorphisms on P450 oxidoreductase and peroxisome proliferator-activated receptor alpha on tacrolimus pharmacokinetics in renal transplant recipients","volume":"19","author":"Si","year":"2019","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.apsb.2026.03.030_bib189","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/FPC.0b013e32830054ac","article-title":"Pharmacogenetics of P450 oxidoreductase: effect of sequence variants on activities of CYP1A2 and CYP2C19","volume":"18","author":"Agrawal","year":"2008","journal-title":"Pharmacogenet Genom"},{"key":"10.1016\/j.apsb.2026.03.030_bib190","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/FPC.0b013e32833e0cb5","article-title":"Substrate-specific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductase","volume":"20","author":"Agrawal","year":"2010","journal-title":"Pharmacogenet Genom"},{"key":"10.1016\/j.apsb.2026.03.030_bib191","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/hep.22895","article-title":"Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex","volume":"49","author":"Lucena","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2026.03.030_bib192","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1007\/s11095-013-1007-6","article-title":"Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis","volume":"30","author":"McGill","year":"2013","journal-title":"Pharm Res"},{"key":"10.1016\/j.apsb.2026.03.030_bib193","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1172\/JCI114527","article-title":"Acetylation pharmacogenetics. The slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver","volume":"85","author":"Grant","year":"1990","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2026.03.030_bib194","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1093\/carcin\/bgm085","article-title":"Functional characterization of single-nucleotide polymorphisms and haplotypes of human N-acetyltransferase 2","volume":"28","author":"Zang","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.apsb.2026.03.030_bib195","doi-asserted-by":"crossref","first-page":"7566","DOI":"10.1038\/s41598-020-64508-0","article-title":"Human arylamine N-acetyltransferase 2 genotype-dependent protein expression in cryopreserved human hepatocytes","volume":"10","author":"Salazar-Gonzalez","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2026.03.030_bib196","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.apsb.2016.07.014","article-title":"Isoniazid metabolism and hepatotoxicity","volume":"6","author":"Wang","year":"2016","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.03.030_bib197","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2174\/138920008784892155","article-title":"Interethnic and intraethnic variability of NAT2 single nucleotide polymorphisms","volume":"9","author":"Garcia-Martin","year":"2008","journal-title":"Curr Drug Metabol"},{"key":"10.1016\/j.apsb.2026.03.030_bib198","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s002040050081","article-title":"Influence of inducers and inhibitors of cytochrome P450 on the hepatotoxicity of hydrazine in vivo","volume":"68","author":"Jenner","year":"1994","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.apsb.2026.03.030_bib199","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1128\/AAC.49.5.1733-1738.2005","article-title":"Should we use N-acetyltransferase type 2 genotyping to personalize isoniazid doses?.","volume":"49","author":"Kinzig-Schippers","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2026.03.030_bib200","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1074\/jbc.273.3.1684","article-title":"Functional analysis of a canalicular multispecific organic anion transporter cloned from rat liver","volume":"273","author":"Ito","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2026.03.030_bib201","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/sj.tpj.6500403","article-title":"Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex","volume":"7","author":"Haenisch","year":"2007","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.apsb.2026.03.030_bib202","article-title":"ABCC2 induces metabolic vulnerability and cellular ferroptosis via enhanced glutathione efflux in gastric cancer","volume":"14","author":"Wang","year":"2024","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.apsb.2026.03.030_bib203","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/tpj.2012.20","article-title":"Functional characterization of ABCC2 promoter polymorphisms and allele-specific expression","volume":"13","author":"Nguyen","year":"2013","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.apsb.2026.03.030_bib204","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/01.fpc.0000178311.02878.83","article-title":"Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability","volume":"15","author":"Wang","year":"2005","journal-title":"Pharmacogenet Genom"},{"key":"10.1016\/j.apsb.2026.03.030_bib205","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191388","article-title":"Physiological expression and function of the MDR1 transporter in cytotoxic T lymphocytes","volume":"217","author":"Chen","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.apsb.2026.03.030_bib206","doi-asserted-by":"crossref","first-page":"35669","DOI":"10.1074\/jbc.M103792200","article-title":"Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans","volume":"276","author":"Tirona","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2026.03.030_bib207","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/clpt.2010.255","article-title":"Common nonsynonymous substitutions in SLCO1B1 predispose to statin intolerance in routinely treated individuals with type 2 diabetes: a go-DARTS study","volume":"89","author":"Donnelly","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.apsb.2026.03.030_bib208","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/pbc.23074","article-title":"Polymorphisms of the SLCO1B1 gene predict methotrexate-related toxicity in childhood acute lymphoblastic leukemia","volume":"57","author":"Lopez-Lopez","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.apsb.2026.03.030_bib209","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1074\/jbc.M114.607028","article-title":"Naturally processed non-canonical HLA-A\u221702:01 presented peptides","volume":"290","author":"Hassan","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2026.03.030_bib210","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/hep.26077","article-title":"Human leukocyte antigen (HLA)-B\u221757:01-restricted activation of drug-specific T cells provides the immunological basis for flucloxacillin-induced liver injury","volume":"57","author":"Monshi","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2026.03.030_bib211","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/hep.30660","article-title":"HLA-B\u221735:01 allele is a potential biomarker for predicting polygonum multiflorum-induced liver injury in humans","volume":"70","author":"Li","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2026.03.030_bib212","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/ng2111","article-title":"Unusual selection on the KIR3DL1\/S1 natural killer cell receptor in Africans","volume":"39","author":"Norman","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.apsb.2026.03.030_bib213","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1053\/gast.1997.v112.pm9178696","article-title":"Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis","volume":"112","author":"Strettell","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2026.03.030_bib214","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.bi.64.070195.000525","article-title":"Superoxide radical and superoxide dismutases","volume":"64","author":"Fridovich","year":"1995","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.apsb.2026.03.030_bib215","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s00018-003-3206-5","article-title":"Diversity of structures and properties among catalases","volume":"61","author":"Chelikani","year":"2004","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.apsb.2026.03.030_bib216","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1016\/j.bbagen.2012.11.020","article-title":"Glutathione peroxidases","volume":"1830","author":"Brigelius-Flohe","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.apsb.2026.03.030_bib217","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev.bi.54.070185.001321","article-title":"Thioredoxin","volume":"54","author":"Holmgren","year":"1985","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.apsb.2026.03.030_bib218","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00008571-200303000-00004","article-title":"The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria","volume":"13","author":"Sutton","year":"2003","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.apsb.2026.03.030_bib219","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1124\/pr.56.2.6","article-title":"Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity","volume":"56","author":"Minotti","year":"2004","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.apsb.2026.03.030_bib220","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/bcp.12885","article-title":"Mechanism of isoniazid-induced hepatotoxicity: then and now","volume":"81","author":"Metushi","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.apsb.2026.03.030_bib221","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.redox.2018.04.019","article-title":"Mechanisms of acetaminophen-induced liver injury and its implications for therapeutic interventions","volume":"17","author":"Yan","year":"2018","journal-title":"Redox Biol"},{"key":"10.1016\/j.apsb.2026.03.030_bib222","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.tips.2015.05.001","article-title":"Nitric oxide in liver diseases","volume":"36","author":"Iwakiri","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.apsb.2026.03.030_bib223","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/03602532.2020.1817061","article-title":"Regulation of cytochrome P450 enzyme activity and expression by nitric oxide in the context of inflammatory disease","volume":"52","author":"Morgan","year":"2020","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.apsb.2026.03.030_bib224","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev.immunol.15.1.323","article-title":"Nitric oxide and macrophage function","volume":"15","author":"MacMicking","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.apsb.2026.03.030_bib225","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/sj.ejhg.5200522","article-title":"Genomic structure and transcript variants of the human methylenetetrahydrofolate reductase gene","volume":"8","author":"Homberger","year":"2000","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.apsb.2026.03.030_bib226","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s003359900838","article-title":"Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR)","volume":"9","author":"Goyette","year":"1998","journal-title":"Mamm Genome"},{"key":"10.1016\/j.apsb.2026.03.030_bib227","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng0595-111","article-title":"A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase","volume":"10","author":"Frosst","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.apsb.2026.03.030_bib228","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0021-9150(00)00671-7","article-title":"The 1298A--C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine","volume":"156","author":"Weisberg","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.apsb.2026.03.030_bib229","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1086\/301825","article-title":"A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?.","volume":"62","author":"van der Put","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.apsb.2026.03.030_bib230","doi-asserted-by":"crossref","DOI":"10.11131\/2015\/101178","article-title":"Nuclear receptors in drug metabolism, drug response and drug interactions","volume":"2","author":"Prakash","year":"2015","journal-title":"Nucl Recept Res"},{"key":"10.1016\/j.apsb.2026.03.030_bib231","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrd753","article-title":"PXR, CAR and drug metabolism","volume":"1","author":"Willson","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2026.03.030_bib232","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nm.3104","article-title":"Human PXR modulates hepatotoxicity associated with rifampicin and isoniazid co-therapy","volume":"19","author":"Li","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2026.03.030_bib233","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/sj.bjp.0707611","article-title":"Rifampicin exacerbates isoniazid-induced toxicity in human but not in rat hepatocytes in tissue-like cultures","volume":"153","author":"Shen","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.apsb.2026.03.030_bib234","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1007\/s00204-014-1348-x","article-title":"Pregnane X receptor activation and silencing promote steatosis of human hepatic cells by distinct lipogenic mechanisms","volume":"89","author":"Bitter","year":"2015","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.apsb.2026.03.030_bib235","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nri2748","article-title":"Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells","volume":"10","author":"Glass","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2026.03.030_bib236","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1172\/JCI26283","article-title":"Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation","volume":"116","author":"Zhou","year":"2006","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2026.03.030_bib237","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40246-023-00478-4","article-title":"In silico prioritisation of microRNA-associated common variants in multiple sclerosis","volume":"17","author":"Fashina","year":"2023","journal-title":"Hum Genom"},{"key":"10.1016\/j.apsb.2026.03.030_bib238","doi-asserted-by":"crossref","first-page":"6354","DOI":"10.1073\/pnas.92.14.6354","article-title":"Correction of chromosomal instability and sensitivity to diverse mutagens by a cloned cDNA of the XRCC3 DNA repair gene","volume":"92","author":"Tebbs","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2026.03.030_bib239","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.canlet.2004.08.018","article-title":"The RAD51 gene family, genetic instability and cancer","volume":"219","author":"Thacker","year":"2005","journal-title":"Cancer Lett"},{"key":"10.1016\/j.apsb.2026.03.030_bib240","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nature10540","article-title":"Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules","volume":"479","author":"Moussion","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.03.030_bib241","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/ni.2309","article-title":"Regulation of T(H)2 development by CXCR5+ dendritic cells and lymphotoxin-expressing B cells","volume":"13","author":"Le\u00f3n","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1016\/j.apsb.2026.03.030_bib242","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.chom.2011.06.002","article-title":"Lymphotoxin controls the IL-22 protection pathway in gut innate lymphoid cells during mucosal pathogen challenge","volume":"10","author":"Tumanov","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.apsb.2026.03.030_bib243","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/ni.2403","article-title":"Lymphotoxin regulates commensal responses to enable diet-induced obesity","volume":"13","author":"Upadhyay","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1016\/j.apsb.2026.03.030_bib244","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12862-019-1516-y","article-title":"Multiple selective sweeps of ancient polymorphisms in and around LT\u03b1 located in the MHC class III region on chromosome 6","volume":"19","author":"Campbell","year":"2019","journal-title":"BMC Evol Biol"},{"key":"10.1016\/j.apsb.2026.03.030_bib245","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.phrs.2017.05.001","article-title":"UDP-glucuronosyltransferases (UGTs) and their related metabolic cross-talk with internal homeostasis: a systematic review of UGT isoforms for precision medicine","volume":"121","author":"Yang","year":"2017","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.apsb.2026.03.030_bib246","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.biocel.2013.02.019","article-title":"The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification","volume":"45","author":"Rowland","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.apsb.2026.03.030_bib247","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1124\/dmd.107.016402","article-title":"Interactions between Human UGT1A1, UGT1A4, and UGT1A6 affect their enzymatic activities","volume":"35","author":"Fujiwara","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.apsb.2026.03.030_bib248","article-title":"Genetic testing of UGT1A1 in the diagnosis of Gilbert syndrome: the discovery of seven novel variants in the Chinese population","volume":"10","author":"Gu","year":"2022","journal-title":"Mol Genet Genom Med"},{"key":"10.1016\/j.apsb.2026.03.030_bib249","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.toxlet.2017.11.038","article-title":"Effect of UGT2B7\u22172 and CYP2C8\u22174 polymorphisms on diclofenac metabolism","volume":"284","author":"Lazarska","year":"2018","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.apsb.2026.03.030_bib250","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","article-title":"Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study","volume":"5","author":"Yu","year":"2020","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.apsb.2026.03.030_bib251","doi-asserted-by":"crossref","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.apsb.2026.03.030_bib252","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrgastro.2010.213","article-title":"NF-\u03baB in the liver\u2014linking injury, fibrosis and hepatocellular carcinoma","volume":"8","author":"Luedde","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2026.03.030_bib253","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s00204-015-1536-3","article-title":"Activation of the Nrf2 response by intrinsic hepatotoxic drugs correlates with suppression of NF-\u03baB activation and sensitizes toward TNF\u03b1-induced cytotoxicity","volume":"90","author":"Herpers","year":"2016","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.apsb.2026.03.030_bib254","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/hmg\/ddh008","article-title":"Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis","volume":"13","author":"Karban","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.apsb.2026.03.030_bib255","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1073\/pnas.94.7.3195","article-title":"Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation","volume":"94","author":"Wilson","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2026.03.030_bib256","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0161-5890(97)00052-7","article-title":"The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription","volume":"34","author":"Kroeger","year":"1997","journal-title":"Mol Immunol"},{"key":"10.1016\/j.apsb.2026.03.030_bib257","doi-asserted-by":"crossref","first-page":"18138","DOI":"10.1074\/jbc.M000379200","article-title":"Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation","volume":"275","author":"Terry","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2026.03.030_bib258","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3892\/ijmm.2016.2595","article-title":"Interleukin-6 and rs1800796 locus single nucleotide polymorphisms in response to hypoxia\/reoxygenation in hepatocytes","volume":"38","author":"Wang","year":"2016","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.apsb.2026.03.030_bib259","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0065-2571(02)00038-9","article-title":"Importance of phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesis","volume":"43","author":"Talalay","year":"2003","journal-title":"Adv Enzym Regul"},{"key":"10.1016\/j.apsb.2026.03.030_bib260","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1038\/sj.emboj.7600248","article-title":"Heme regulates gene expression by triggering Crm1-dependent nuclear export of Bach1","volume":"23","author":"Suzuki","year":"2004","journal-title":"EMBO J"},{"key":"10.1016\/j.apsb.2026.03.030_bib261","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1128\/MCB.16.11.6083","article-title":"Bach proteins belong to a novel family of BTB-basic leucine zipper transcription factors that interact with MAFK and regulate transcription through the NF-E2 site","volume":"16","author":"Oyake","year":"1996","journal-title":"Mol Cellular Biol"},{"key":"10.1016\/j.apsb.2026.03.030_bib262","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.3390\/ijms21134777","article-title":"NRF2, a transcription factor for stress response and beyond","volume":"21","author":"He","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.03.030_bib263","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tibs.2014.02.002","article-title":"The Nrf2 regulatory network provides an interface between redox and intermediary metabolism","volume":"39","author":"Hayes","year":"2014","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.apsb.2026.03.030_bib264","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/cvr\/cvae250","article-title":"NRF2 activation in the heart induces glucose metabolic reprogramming and reduces cardiac dysfunction via upregulation of the pentose phosphate pathway","volume":"121","author":"Zoccarato","year":"2024","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.apsb.2026.03.030_bib265","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1080\/15548627.2016.1208889","article-title":"Transcription factor NFE2L2\/NRF2 is a regulator of macroautophagy genes","volume":"12","author":"Pajares","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.apsb.2026.03.030_bib266","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/toxsci\/kfn079","article-title":"Genetic or pharmacologic amplification of Nrf2 signaling inhibits acute inflammatory liver injury in mice","volume":"104","author":"Osburn","year":"2008","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.apsb.2026.03.030_bib267","doi-asserted-by":"crossref","first-page":"7369","DOI":"10.1038\/sj.onc.1206940","article-title":"The role of glutathione-S-transferase in anti-cancer drug resistance","volume":"22","author":"Townsend","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.apsb.2026.03.030_bib268","article-title":"The role of glutathione S-transferases in human disease pathogenesis and their current inhibitors","volume":"12","author":"Alnasser","year":"2025","journal-title":"Genes Dis"},{"key":"10.1016\/j.apsb.2026.03.030_bib269","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.1038\/sj.onc.1209576","article-title":"Human glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2\u2013ASK1 signals","volume":"25","author":"Wu","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.apsb.2026.03.030_bib270","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3892\/ol.2012.1098","article-title":"GSTP1 negatively regulates Stat3 activation in epidermal growth factor signaling","volume":"5","author":"Kou","year":"2013","journal-title":"Oncol Lett"},{"key":"10.1016\/j.apsb.2026.03.030_bib271","doi-asserted-by":"crossref","first-page":"83","DOI":"10.7150\/jca.36495","article-title":"Glutathione S-transferase A1 suppresses tumor progression and indicates better prognosis of human primary hepatocellular carcinoma","volume":"11","author":"Liu","year":"2020","journal-title":"J Cancer"},{"key":"10.1016\/j.apsb.2026.03.030_bib272","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2022.102206","article-title":"Network analysis of genome-wide association studies for drug target prioritisation","volume":"71","author":"Barrio-Hernandez","year":"2022","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.apsb.2026.03.030_bib273","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.zefq.2022.11.007","article-title":"From standard systematic reviews to living systematic reviews","volume":"176","author":"Breuer","year":"2023","journal-title":"Z Evid Fortbild Qual Gesundhwes"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526001899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526001899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T17:11:18Z","timestamp":1783012278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383526001899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":272,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2211383526001899"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2026.03.030","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic review on genetic polymorphisms associated with idiosyncratic drug-induced liver injury (iDILI): iDILInet as an interactive visualization tool","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2026.03.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}